The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 25, 2018

Filed:

Sep. 16, 2015
Applicant:

Pierre Fabre Medicament, Boulogne-Billancourt, FR;

Inventors:

Charlotte Beau-Larvor, Jonzier Epagny, FR;

Liliane Goetsch, Ayze, FR;

Assignee:

PIERRE FABRE MEDICAMENT, Boulogne-Billancourt, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/53 (2006.01); G01N 33/50 (2006.01); C07K 14/71 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01); C07K 16/30 (2006.01); G01N 33/68 (2006.01); A61K 38/47 (2006.01); C07K 16/18 (2006.01); C12N 9/24 (2006.01); A61K 47/68 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/5035 (2013.01); A61K 38/47 (2013.01); A61K 47/6843 (2017.08); A61K 47/6851 (2017.08); C07K 14/71 (2013.01); C07K 16/18 (2013.01); C07K 16/2803 (2013.01); C07K 16/30 (2013.01); C07K 16/32 (2013.01); C12N 9/2497 (2013.01); G01N 33/6854 (2013.01); A61K 2039/505 (2013.01); C07K 2317/14 (2013.01); C07K 2317/20 (2013.01); C07K 2317/33 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/77 (2013.01); C07K 2317/92 (2013.01); C07K 2319/30 (2013.01); C07K 2319/74 (2013.01); C12Y 302/02022 (2013.01); G01N 2333/912 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01);
Abstract

The present invention relates to a novel antigen binding protein, in particular a monoclonal antibody, capable of binding specifically to the protein Axl as well as the amino and nucleic acid sequences coding for said protein. From one aspect, the invention relates to a novel antigen binding protein, or antigen binding fragments, capable of binding specifically to Axl and, by inducing internalization of Axl, being internalized into the cell. The invention also comprises the use of said antigen binding protein as an addressing product in conjugation with other anti-cancer compounds, such as toxins, radio-elements or drugs, and the use of same for the treatment of certain cancers.


Find Patent Forward Citations

Loading…